Implementation Guide CH VACD
4.0.1 - trial-use
Implementation Guide CH VACD
4.0.1 - trial-use
This page is part of the CH VACD (R4) (v4.0.1: STU 4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
| Official URL: http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-allergyintolerance-cs | Version: 4.0.1 | |||
| Active as of 2023-12-28 | Computable Name: SwissAllergyIntoleranceCodesystem | |||
| Other Identifiers: id: ch-vacd-allergyintolerance-cs (use: OFFICIAL) | ||||
Copyright/Legal: CC0-1.0 |
||||
AllergyIntolerance codes in Switzerland.
This Code system is referenced in the content logical definition of the following value sets:
This case-sensitive code system http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-allergyintolerance-cs defines the following codes:
Additional Language Displays
| Code | Deutsch (Schweiz) (German (Switzerland), de) | French (Switzerland) (fr) | Italian (Switzerland) (it) |
| allergyvaccinevarizella | Unerwünschte Wirkung eines Varizellen-Impfstoffs | Effet indésirable du vaccin contre la varicelle | Adverse reaction to component of vaccine product containing varicella antigen |
| allergyvaccinehpv | Unerwünschte Wirkung eines Humanen-Papillomaviren-Impfstoffs | Effet indésirable du vaccin contre le papillomavirus humain | Adverse reaction to component of vaccine product containing human papillomavirus antigen |
| allergyvaccineherpeszoster | Unerwünschte Wirkung eines Herpes-Zoster-Impfstoffs | Effet indésirable du vaccin contre le zona | Adverse reaction to component of vaccine product containing Herpes zoster |
| allergyvaccinefsme | Unerwünschte Wirkung eines FSME-Impfstoffs | Effet indésirable du vaccin contre la FSME | Adverse reaction to component of vaccine product containing tick-borne encephalitis virus antigen |